PLoS ONE (Jan 2016)

AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical Trials.

  • Graham M Wheeler,
  • Michael J Sweeting,
  • Adrian P Mander

DOI
https://doi.org/10.1371/journal.pone.0159026
Journal volume & issue
Vol. 11, no. 7
p. e0159026

Abstract

Read online

In phase I cancer clinical trials, the maximum tolerated dose of a new drug is often found by a dose-escalation method known as the A + B design. We have developed an interactive web application, AplusB, which computes and returns exact operating characteristics of A + B trial designs. The application has a graphical user interface (GUI), requires no programming knowledge and is free to access and use on any device that can open an internet browser. A customised report is available for download for each design that contains tabulated operating characteristics and informative plots, which can then be compared with other dose-escalation methods. We present a step-by-step guide on how to use this application and provide several illustrative examples of its capabilities.